Jade Biosciences, Inc. (JBIO) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Jade Biosciences, Inc. (JBIO) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $817.9M, listed on NASDAQ, employing roughly 50 people, carrying a beta of 1.52 to the broader market. Jade Biosciences, Inc. Led by Tom Frohlich, public since 2025-04-29.
Snapshot as of May 15, 2026.
- Spot Price
- $23.54
- Total OI
- 462